Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis - Widder, Stefanie; Carmody, Lisa A.; Opron, Kristopher; Kalikin, Linda M.; Caverly, Lindsay J.; LiPuma, John J. (Nature communications, 2024)
Keywords: 45; 45/23; 631/114/2397; 631/250/254; 631/326/2565/2134; Adolescent; Adult; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Bacteria - classification; Bacteria - genetics; Bacteria - isolation & purification; Bronchiectasis; Chronic obstructive pulmonary disease; Community structure; Cystic fibrosis; Cystic Fibrosis - microbiology; Disease Progression; Dysbacteriosis; Dysbiosis - microbiology; Female; Health services; Humanities and Social Sciences; Humans; Lung - microbiology; Lung diseases; Male; Microbiomes; Microbiota; Microorganisms; multidisciplinary; Pathogens; Prospective Studies; Pulmonary Disease, Chronic Obstructive - microbiology; Respiratory function; Respiratory tract; Science; Science (multidisciplinary); Signs and symptoms; Sputum; Sputum - microbiology; Stochasticity; Treatment Outcome; Young Adult